Kenvue Stock (NYSE:KVUE)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$21.87

52W Range

$17.67 - $24.46

50D Avg

$22.61

200D Avg

$21.82

Market Cap

$42.38B

Avg Vol (3M)

$15.97M

Beta

0.98

Div Yield

$0.81 (3.69%)

KVUE Company Profile


Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Show More

Industry

Household & Personal Products

Sector

Consumer Defensive

Exchange

NYSE

ADR

-

Country

US

Employees

22,000

IPO Date

May 04, 2023

Website

KVUE Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24
Asia Pacific$2.97B
EMEA$3.56B
Latin America$1.34B
North America$7.58B
UNITED STATES$6.72B

Fiscal year ends in Dec 24 | Currency in USD

KVUE Financial Summary


Dec 24Dec 23Dec 22
Revenue$15.46B$15.44B$14.95B
Operating Income$1.84B$2.51B$2.67B
Net Income$1.03B$1.66B$2.06B
EBITDA$1.84B$3.17B$3.64B
Basic EPS$0.54$0.90$1.08
Diluted EPS$0.54$0.87$1.08

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Feb 06, 25 | 8:00 AM
Q3 24Nov 07, 24 | 8:00 AM
Q2 24Aug 06, 24 | 8:30 AM